Picture of Orchestra Biomed Holdings logo

OBIO — Orchestra Biomed Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Orchestra Biomed To Receive Up To $21 Million In Proceeds From Acquisition Of Vivasure By Haemonetics

Jan 12 (Reuters) - Haemonetics Corp HAE.N:

ORCHESTRA BIOMED TO RECEIVE UP TO $21 MILLION IN PROCEEDS FROM ACQUISITION OF VIVASURE BY HAEMONETICS

Source text: ID:nGNX269v3M

Further company coverage: HAE.N

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Orchestra Biomed Holdings

See all news